DOI: https://dx.doi.org/10.18565/therapy.2023.6.98-105
Alieva A.M., Teplova N.V., Reznik E.V., Muravyev Ya.E., Tikhomirova A.S., Nikitin I.G.
1) FGAOU HE Russian National Research Medical University named after N.N. N.I. Pirogov” of the Ministry of Health of Russia, Moscow; 2) FGAU “National Medical Research Center “Treatment and Rehabilitation Center”” of the Ministry of Health of Russia, Moscow
1. Khan K., Kim J.A., Gurgu A. et al. Innovations in cardiac implantable electronic devices. Cardiovasc Drugs Ther. 2022; 36(4): 763–75. https://dx.doi.org/10.1007/s10557-021-07163-5. 2. Assa S., Vernooy K., van Stipdonk A.M.W. Cardiovascular implantable electronic devices enabled remote heart failure monitoring; What we have learned and where to go next. J Cardiovasc Dev Dis. 2023; 10(4): 152. https://dx.doi.org/10.3390/jcdd10040152. 3. Vandenberk B., Raj S.R. Remote patient monitoring: What have we learned and where are we going? Curr Cardiovasc Risk Rep. 2023; 17(6): 103–15. https://dx.doi.org/10.1007/s12170-023-00720-7. 4. Afzal M.R., Nadkarni A., Bhuta S. et al. Approaches for successful implantation of cardiac implantable devices in patients with persistent left superior vena cava. J Innov Card Rhythm Manag. 2023; 14(4): 5403–9. https://dx.doi.org/10.19102/icrm.2023.14043. 5. Дворецкий Л.И., Ваколюк Р.М., Каптаева А.К. с соавт. Инфекции, ассоциированные с имплантацией кардиостимуляторов. Архивъ внутренней медицины. 2017; 7(2): 233–240. [Dvoretsky L.I., Vakoluk R.M., Kaptaeva A.K. et al. Infection associated with the implantation of cardiovascular implantable electronic devices. Arkhiv vnutrenney meditsiny = The Russian Archives of Internal Medicine. 2017; 7(2): 233–240 (In Russ.)]. https://dx.doi.org/10.20514/2226-6704-2017-7-3-233-240. EDN: YPDRRN. 6. Barbar T., Patel R., Thomas G. et al. Strategies to prevent cardiac implantable electronic device infection. J Innov Card Rhythm Manag. 2020; 11(1): 3949–56. https://dx.doi.org/10.19102/icrm.2020.110102. 7. Gill J. Implantable cardiovascular devices: Current and emerging technologies for remote heart failure monitoring. Cardiol Rev. 2023; 31(3): 128–38. https://dx.doi.org/10.1097/CRD.0000000000000432. 8. Tanawuttiwat T., Das M.K., Miller J.M. et al. Device-device interaction between cardiac implantable electronic devices and continuous-flow left ventricular assist devices. Heart Rhythm. 2023; 20(6): 918–26. https://dx.doi.org/10.1016/j.hrthm.2023.02.020. 9. Pisano E.C., Mitacchione G., Pappalardo A. et al. Prevention, diagnosis and treatment of cardiac implantable electronic device infections. Position paper of the Italian Association of Arrhythmology and Cardiac Pacing (AIAC). G Ital Cardiol (Rome). 2023; 24(7): 551–70. https://dx.doi.org/10.1714/4060.40435. 10. Khubrani R., Alghamdi A.S., Alsubaie A.A. et al. Rate of cardiovascular implantable electronic device-related infection at a Tertiary Hospital in Saudi Arabia: A retrospective cohort study. Cureus. 2022; 14(7): e27078. https://dx.doi.org/10.7759/cureus.27078. 11. Phillips P., Krahn A.D., Andrade J.G. et al. Treatment and prevention of cardiovascular implantable electronic device (CIED) Infections. CJC Open. 2022; 4(11): 946–58. https://dx.doi.org/10.1016/j.cjco.2022.07.010. 12. Canadian Institute for Health Information Implantable medical devices in Canada: Insights into high-volume procedures and associated costs. URL: https://secure.cihi.ca/free_products/implantable-medical-devices-report-en.pdf (date of access – 01.08.2023). 13. Blomstrom-Lundqvist C., Traykov V., Erba P.A. et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020; 41(21): 2012–32.https://dx.doi.org/10.1093/eurheartj/ehaa010. 14. Daneman N., Homenauth E., Saskin R. et al. The predictors of economic burden of early-, mid- and late-onset cardiac implantable electronic device infections: A retrospective cohort study in Ontario, Canada. Clin Microbiol Infect. 2020; 26(2): 255.e1–255.e6.https://dx.doi.org/10.1016/j.cmi.2019.02.009. 15. Демин А.А., Кобалава Ж.Д., Скопин И.И. с соавт. Инфекционный эндокардит и инфекция внутрисердечных устройств. Клинические рекомендации 2021. Российский кардиологический журнал. 2022; 27(10): 113–192. [Demin A.A., Kobalava Z.D., Skopin I.I. et al. Infectious endocarditis and infection of intracardiac devices in adults. Clinical guidelines 2021. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2022; 27(10): 113–192 (In Russ.)].https://dx.doi.org/10.15829/1560-4071-2022-5233. EDN: DCXUXV. 16. Topaz M., Chorin E., Schwartz A.L. et al. Regional antibiotic delivery for implanted cardiovascular electronic device infections.J Am Coll Cardiol. 2023; 81(2): 119–33. https://dx.doi.org/10.1016/j.jacc.2022.10.022. 17. King T.L., Chew D.S., Leal J. et al. Complex cardiac implantable electronic device infections in Alberta, Canada: An epidemiologic cohort study of validated administrative data. Infect Control Hosp Epidemiol. 2023; 5: 1–7.https://dx.doi.org/10.1017/ice.2023.48. Online ahead of print. 18. Han H.C., Hawkins N.M., Pearman C.M. et al. Epidemiology of cardiac implantable electronic device infections: incidence and risk factors. Europace. 2021; 23(23 Suppl 4): iv3–iv10. https://dx.doi.org/10.1093/europace/euab042. 19. Song J., Tark A., Larson E.L. The relationship between pocket hematoma and risk of wound infection among patients with a cardiovascular implantable electronic device: An integrative review. Heart Lung. 2020; 49(1): 92–98.https://dx.doi.org/10.1016/j.hrtlng.2019.09.009. 20. Richardson C.J., Prempeh J., Gordon K.S. et al. Surgical techniques, complications, and long-term health effects of cardiac implantable electronic devices. Cureus. 2021; 13(1): e13001. https://dx.doi.org/10.7759/cureus.13001. 21. Palmeri N.O., Kramer D.B., Karchmer A.W. et al. A review of cardiac implantable electronic device infections for the practicing electrophysiologist. JACC Clin Electrophysiol. 2021; 7(6): 811–24. https://dx.doi.org/10.1016/j.jacep.2021.03.021. 22. Vasilev S. Strategies for prevention of surgical site infection in patients with CIED implantation: A literature review. Cureus. 2021; 13(1): e13021. https://dx.doi.org/10.7759/cureus.13021. 23. Golzio P.G., Magnano S., Lio M. et al. Occult bacteraemia in cardiac implantable electronic device patients: a review of diagnostic workflow and mandatory therapy. J Cardiovasc Med (Hagerstown). 2019; 20(5): 271–77.https://dx.doi.org/10.2459/JCM.0000000000000754. 24. Marciniak-Emmons M.B., Swierzynska E., Mazurek A. et al. Computed tomography with positron emission tomography is more useful in local than systemic infectious process related to cardiac implanted electrotherapy device: a prospective controlled multicenter diagnostic intervention PET-Guidance Trial. Int J Cardiovasc Imaging. 2022; 38(12): 2753–61.https://dx.doi.org/10.1007/s10554-022-02663-3. 25. Esquer Garrigos Z., George M.P., Khalil S. et al. Predictors of bloodstream infection in patients presenting with cardiovascular implantable electronic device pocket infection. Open Forum Infect Dis. 2019; 6(4): ofz084. https://dx.doi.org/10.1093/ofid/ofz084.
Amina M. Alieva, PhD in Medical Sciences, associate professor of the Department of hospital therapy named after G.N. Storozhakov of the Faculty of general medicine, N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia. ORCID: https://orcid.org/0000-0001-5416-8579.
Natalia V. Teplova, MD, professor, head of the Department of clinical pharmacology named after Yu.B. Belousov of the Faculty of general medicine, N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia. ORCID: https://orcid.org/0000-0002-7181-4680
Elena V. Reznik, MD, professor, head of the Department of propaedeutics of internal diseases of the Faculty of general medicine, N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia. ORCID: https://orcid.org/0000-0001-7479-418X.
Yaroslav E. Muraviev, head of the Department of medical rehabilitation of adults, National Medical Research Center «Treatment and Rehabilitation Center» of the Ministry of Healthcare of Russia.
ORCID: https://orcid.org/0009-0004-3969-3630.
Anna S. Tikhomirova, assistant at the Department of hospital therapy of the Faculty of general medicine, N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia.
ORCID: https://orcid.org/0000-0003-0240-7587
Igor G. Nikitin, MD, professor, head of the Department of hospital therapy named after G.N. Storozhakov of the Faculty of general medicine, N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia. ORCID: https://orcid.org/0000-0003-1699-0881